Skip to main content
    S

    Sanara Medtech Inc (SMTI)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $32.76
    +0.41 (+1.27%)

    Market Cap: $297.06M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Sanara Medtech Inc (SMTI) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Sanara Medtech (SMTI) trades at 2.6x sales and 37.5x book value. Its P/S of 2.6x is below its 5-year median of 3.9x. Its forward P/E is 217.4x.

    Current Multiples

    Its enterprise value is 22.1x its EBITDA.

    MultipleValue
    P/E (trailing)N/A
    Forward P/E217.4x
    Price to sales2.6x
    Price to book37.5x
    EV/EBITDA22.1x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/S2.6x3.9xN/A
    P/B37.5x7.3xN/A
    Medians of month-end values through Oct 2026: 60 months (5-year).

    Valuation History

    Over the 7 of the 10 year ends shown that have a P/S, its P/S ranged from 1.8x in 2019 to 18.6x in 2020.

    Year endPriceP/EP/SP/B
    2025$23.35N/A2.0x34.0x
    2024$33.20N/A3.3x7.2x
    2023$41.10N/A5.3x7.8x
    2022$45.50N/A8.0x9.0x
    2021$29.55N/A9.0x7.3x
    2020$49.90N/A18.6x50.5x
    2019$16.10N/A1.8x15.2x
    2018$3.2775.3xN/A4.9x
    2017$6.00201.3xN/AN/A
    2016$3.79N/AN/AN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    Frequently Asked Questions About SMTI

    What is SMTI's forward P/E ratio?

    Sanara Medtech has a forward P/E ratio of 217.4x.

    What is SMTI's price to sales ratio?

    Sanara Medtech has a price to sales ratio of 2.6x.